Surface Oncology Inc 's

• SURF's Stock Performance relative to its Competitors

Adaptimmune Therapeutics Plc Share Performance -91.19% This Year

Adaptimmune Therapeutics Plc Profile Adaptimmune Therapeutics Plc is a biopharmaceutical company that focuses on developing and commercializing innovative cancer immunotherapy products. Their business model revolves around leveraging their T-cell receptor platform to engineer and develop targeted immunotherapies for patients with various types of cancer. More about Adaptimmune Therapeutics Plc's Market Share

Curis Inc Share Performance -14.13% Over The Past 5 Days

Curis Inc Profile Curis Inc's business model revolves around the development and commercialization of innovative cancer therapies. They focus on discovering and advancing drug candidates targeting specific molecular pathways involved in cancer growth and survival. The company collaborates with pharmaceutical partners to conduct clinical trials and seek regulatory approval for their products. More about Curis Inc 's Market Share

Fate Therapeutics Inc Share Performance -6.12% Over The Past 5 Days

Fate Therapeutics Inc Profile Fate Therapeutics Inc's business model revolves around the development and commercialization of innovative cell-based therapies to treat various diseases. More about Fate Therapeutics Inc 's Market Share

Fresh Tracks Therapeutics Inc Share Performance +25.50% This Year

Fresh Tracks Therapeutics Inc Profile Fresh Tracks Therapeutics Inc is a biotechnology company that focuses on developing innovative therapies for various diseases. Their business model revolves around conducting research and development to discover new drug candidates, conducting clinical trials to test their effectiveness, and ultimately bringing these therapies to market through partnerships or direct sales. They aim to monetize their discoveries through licensing agreements, product sales, and collaborations with other pharmaceutical companies. More about Fresh Tracks Therapeutics Inc 's Market Share

Greenlight Biosciences Holdings Pbc Share Performance +0.47% Over The Past 5 Days

Greenlight Biosciences Holdings Pbc Profile Greenlight Biosciences Holdings Pbc's business model focuses on using proprietary cell-free bioprocessing technology to produce sustainable and environmentally friendly bio-based products. More about Greenlight Biosciences Holdings Pbc's Market Share

Sources: Surface Oncology Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Thursday, September 10, 2026 1:46 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Surface Oncology Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.